Liang-I Kang

10PUBLICATIONS
97CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
Treg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancer.

|Aug 15, 2025
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer.

Graham D Hogg, Alyssa G Weinstein, Natalie L Kingston

|Dec 16, 2024
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma.

Naomi Yamamoto, Stephanie Dobersch, Ian Loveless

|Oct 23, 2024
Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy.

Xiuting Liu, John M Baer, Meredith L Stone

|Apr 29, 2024
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer.

Jad I Belle, Devashish Sen, John M Baer

|Aug 10, 2023
Fibrosis induced by resident macrophages has divergent roles in pancreas inflammatory injury and PDAC.

John M Baer, Chong Zuo, Liang-I Kang

Pageof 2

Frequent Collaborators

9 joint publications

David G DeNardo

6 joint publications

Brett L Knolhoff

5 joint publications

Ryan C Fields

5 joint publications

Graham D Hogg